iPMI Magazine Is Proudly Sponsored By:
For a healthier journey.
Healthcare International

HealthCare International Appoints Mark O'Dwyer As Non-Executive Chairman

HealthCare International (HCI) is delighted to announce that Mark O'Dwyer has joined the HCI Global Network Limited Board in November 2021 as Non-Executive Chairman. 

Additionally Mark will become Chairman of the Risk and Audit Committee and will be a member of the Remuneration Committee.

Mark’s most recent role was as Managing Director of Bupa Global. While at Bupa, Mark was a Board member of Bupa Insurance (UK) and Chairman of Bupa Egypt. His experience includes both the commercial and regulatory aspects of the International Private Medical Insurance market.

Mark has extensive financial services and insurance experience from working at AIG, L&G, Royal London, Fidelity International over the previous twenty years before Bupa. Mark is a Fellow of the Institute of Chartered Accountants for England and Wales (ICAEW).

Ian Wood MIoD ACMA CGMA, CEO of HCI said, “Appointing Mark as Chairman is a significant move forward for HCI, his blue chip industry experience and extensive commercial background will help us shape further our product and geographic offerings, I very much look forward to working with Mark in our next stage of building out the HCI business”

Mark O'Dwyer said, "I am delighted to be joining the HCI Board and working with Ian and the team as they continue to identify new opportunities for the business to grow".

Related Reading: Healthcare International (HCI) Announces Management Buyout Backed By Prefequity


Globality Health Withdraws From UK IPMI Market

In light of the compliance challenges created by Brexit, Globality Health is withdrawing from the UK IPMI market. Customers are offered a continuation option with Bupa Global.

Globality Health shall continue business as usual in other key markets such as Germany, Spain and others, which are completely unaffected by this decision.

Globality Health confirms key dates and collaborates with Bupa Global to help honour all customers

From 11 January 2020, Globality Health will no longer quote for any new business or renewal terms with start dates from 1 May 2020 onwards.

All existing policyholders will remain fully protected until the policy’s renewal date - should an illness or injury happen while they are living or working overseas.

Globality Health and Bupa Global have achieved a mutual agreement that allows Globality’s customers to continue their international health plan with Bupa Global. At renewal time, Bupa Global will offer each Globality customer a new quote on favorable and comparable terms.

Globality’s gradual withdrawal from the UK will therefore take until the middle of 2021 to complete.

Why Globality Health is withdrawing from the UK market

Globality is withdrawing from the UK market due to the changes and challenges caused by Brexit. The move shall allow Globality more focus on other markets where it can continue to achieve scale and profitability.

Globality shall continue business as usual in other key markets such as Germany, Spain and others, which are completely unaffected by this decision.

How Bupa Global will deliver continuation cover

Bupa Global’s brand, scale, expertise and strong service model convinced Globality that customers would be in great hands. Dr. Cornelia Roeskau, Globality Health, CCO commented, “After very careful consideration, we have taken the difficult decision to withdraw from the IPMI market in the UK after Brexit. With Bupa Global we have found a partner who shares our values of customer focus and high-end client services. We are happy to be in a position to offer continuity to our valued customers and to know they are in the care-taking hands of this strong and reliable partner.”

At renewal time, each customer will receive a personalized communication including the option to contact Bupa Global. In this context, customers who accept Bupa Global’s terms will do so on a non-advised basis, with Globality acting as an introducer. Customers choosing to accept their policies with Bupa Global will become Bupa Global customers and will no longer have a relationship with Globality.

Teresa Wighton, Bupa Global, UK Group Sales Director, commented, “We are working with Globality following their decision to withdraw from the UK market and look forward to welcoming their customers to Bupa Global. We are offering Globality customers a comparable product so they can continue to be covered for international private medical insurance and get access to leading healthcare, when they need it. We will ensure there is a smooth transfer and fast-track registration to Bupa Global.”  

Globality Health are confident that the customer communications programme they have in place shall help make this a smooth transition process.  Both Globality Health and Bupa Global customer and broker service teams will also be available to further smooth the transition.


Bupa Global Expands International Private Medical Insurance (IPMI) Reach With New Office In Switzerland

Bupa’s international private medical insurance (IPMI) business Bupa Global has announced the opening of a new office in Zurich, Switzerland. The opening follows the approval of a new insurance licence, enabling Bupa Global to sell International Private Medical Insurance (IPMI) policies to corporate customers based in Switzerland.

Under the new licence, businesses in Switzerland can now have access to the most premium global cover for their expat employees while they are working and also travelling. Bupa Global works with businesses to design bespoke offerings which provide rich cover and benefits to meet the needs of globally mobile and globally minded employees. Swiss corporates can also leverage the benefits of Bupa’s global footprint and have access to the largest network of healthcare providers worldwide, where Bupa pays the bills directly. But customers also have the freedom to choose any recognised medical provider worldwide for their treatment.

Commenting on the new office, Sheldon Kenton, Managing Director, Bupa Global said: “We are delighted to announce the opening of our new office in Zurich, allowing us to extend our reach to corporate businesses based in Switzerland, in line with our growth ambitions. The office opening reflects our commitment to have a local presence wherever our customers are located, allowing us to best serve our customers in their own culture, language and time zone.

“As a global financial hub, Zurich hosts a number of multinational businesses, which in turn attract talent from around the world. Looking after the health and wellbeing of these globally minded and globally mobile employees is becoming increasingly important for businesses and we expect to see strong growth potential in the market.” 

Bupa Global currently provides cover to two million customers around the world, of which approximately half are corporate customers.


Sheldon Kenton Appointed Managing Director, Bupa Global

Bupa Global has announced the appointment of Sheldon Kenton to Managing Director, subject to regulatory approval. Sheldon will take over responsibilities from Robert Lang, who was recently appointed Managing Director of Bupa’s International Markets business. 

Robert Lang, Managing Director, Bupa International Markets, said, “Sheldon is an experienced and well-established leader across the global insurance sector, with tremendous knowledge of the IPMI market. He has a clear understanding of Bupa Global’s strategy and priorities and will lead day-to-day operations setting the strategic direction for Bupa Global to drive growth and deliver outstanding customer service.”

Sheldon joined Bupa Global in December 2015 as Global Commercial Director after 18 years with Cigna and was responsible for growing Bupa Global’s corporate sales and health benefits business. Since he joined, Bupa Global has seen record new business performance in the corporate segment, year to date. 

Sheldon Kenton, Managing Director, Bupa Global, said, “I’m really pleased to be taking on this new role and leading Bupa Global in this exciting next chapter of its journey. I am committed to delivering on our strategy, of establishing our new regions and transforming our customer services offering. Together, this will provide our customers and clients with the most premium level of service in their own language, culture and time zone.”

This announcement follows the creation of Bupa International Markets which brings together Bupa Global, Bupa Arabia, Max Bupa in India and Bupa’s domestic businesses, Bupa Hong Kong, Quality HealthCare, Bupa China and Bupa Thailand. This will enable them to fully leverage the unique international capabilities that our Bupa Global offering brings. Bupa Global will also benefit by accessing Bupa’s in-market licenses and networks.

Bupa Global is the international health insurance arm of Bupa, serving two million customers around the world.  We provide products and services for globally minded and mobile people who want the most premium coverage and access to the healthcare they need anytime, anywhere in the world, whether at home or when studying, living, travelling or working abroad.

Bupa Global employs over 1,800 people and has offices in London and Brighton (UK), Miami (USA), Copenhagen (Denmark), Dubai (UAE), and Hong Kong (China), as well as regional offices in Mainland China, Singapore, Egypt, Mexico, Dominican Republic, Bolivia, Brazil, Panama, Guatemala and Ecuador.

International health and medical insurance news

Subscribe to this RSS feed